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Abstract: Snacks combining different functional ingredients could represent a useful therapeutic
strategy against NAFLD. The present study aimed to analyze the effect of two snack formulations
based on carob and wakame flour in the treatment for NAFLD in rats. For this purpose,
metabolic syndrome was induced in 50 adult rats by a high-fat high-fructose diet over eight
weeks. After this period, rats were fed either normal calorie diets supplemented or not with snack
A (1/50 wakame/carob pod) and snack B (1/5 wakame/carob pod) for four additional weeks.
After sacrifice, liver composition and serum parameters were analyzed. Different pathways of
triacylglycerol metabolism in liver were studied including fatty acid oxidation, fatty acid synthesis,
triglyceride assembly and release, fatty acid uptake and glucose uptake. Oxidative stress was also
measured. Snack treatment, and mainly B snack, reduced liver triacylglycerol levels by increasing fat
oxidation. Moreover, this snack reduced oxidative stress. Therefore, this snack formulation could
represent an interesting tool useful for fatty liver treatment.
Keywords: wakame; carob; snack; steatohepatitis; NAFLD
1. Introduction
Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease
worldwide. The incidence of this health alteration has increased within obesity and type 2 diabetes.
Furthermore, many authors consider it as the hepatic manifestation of the metabolic syndrome
(MetS) [1].
The exact prevalence of the NAFLD is unknown because it is generally asymptomatic, but
it is estimated that up to 35% of the western population presents it. From this group of people,
approximately 10% will develop non-alcoholic steatohepatitis, a condition with significantly higher
risk of mortality due to its potential development on cirrhosis and liver cancer [2,3].
The risk factors for NAFLD include central-type obesity, which is usually associated to insulin
resistance. This metabolic situation exerts a negative impact since it causes, due to an increase of
lipolysis in the adipose tissue, an increase in the fatty acid (FA) flux from this tissue to liver, contributing
to an increase in triglyceride (TG) hepatic production. In addition, high glucose concentrations promote
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the hepatic TG synthesis, while high insulin concentrations reduce hepatic apolipoprotein B-100
production and the FA oxidation. As a result, TG accumulation in the liver occurs.
Other factors such as genetics or gut microbiota may also promote this disease, but diet should be
considered as one of the major contributors. For instance, it has been demonstrated that high fructose
consumption, an important component of the western diet, triggers an increase in hepatic de novo
lipogenesis, dyslipidemia, insulin resistance, and obesity with central fat deposits [4].
Nowadays, the therapeutic strategy against NAFLD focuses on facing the etiological factor,
combining pharmacological treatment with changes in eating habits and lifestyle. The usage of
functional foods represents another option, since there are many ingredients that to could help
in fatty liver treatment. Studies with algae, brown ones like wakame (Undaria pinnatifida) among
them, have shown potential to be used on therapies against fatty liver [5–7]. On the other hand,
several investigations carried out in recent years have postulated carob tree (Ceratonia siliqua L.) as an
interesting pulse due to its protective effect at hepatic level, mainly through oxidative stress modulation
pathways [8,9].
The aim of the present study was to analyze the usefulness of snack formulations based on carob
and wakame flour in the treatment of NAFLD in a model of metabolic syndrome induce by feeding.
2. Materials and Methods
2.1. Ethical Approval
The animal experiment was approved in accordance with the Spanish regulation on animal
experimentation (approval no M20_2017_003). All animal experimental protocols were reviewed
and approved by the ethics committee on animal welfare of our institution (Comité Ético de
Experimentación Animal de la Universidad del País Vasco, CEEA-UPV/EHU).
2.2. Animals, Diets, and Experimental Design
The experiment was conducted using 50 six-week-old male Wistar rats (Envigo, Barcelona, Spain).
Rats were housed in polycarbonate metabolic cages (Tecniplast Gazzada, Buguggiate, Italy) and
placed in an air-conditioned room (22 ± 2 ◦C) with a 12-h light-dark cycle. After a six-day adaptation
period, in order to induce MetS, rats were fed a high-fat high-fructose (HFHF) diet (OpenSource Diets,
Denmark; Ref. D09100301), for eight weeks. After this period, randomly 10 rats (randomly selected)
were sacrificed after a 12 h of fasting under anesthesia (chloral hydrate) by cardiac exsanguination
(MS group). The rest of the animals were randomly distributed into four experimental groups (n = 10)
and fed a semi-purified normal-caloric diet (3.9 kcal/g diet) for four weeks: the wheat control group
(WC), the oat control group (OC), the snack A group (SA) and the snack B group (SB) (Supplementary
Figure S1). Snack A contained 0.1% wakame and 5% carob pod in oat and wheat flour dough. Snack
B had the same composition but with 1% of wakame and 5% of carob pod. WC diet represented the
standard normal-caloric diet for the treatment of metabolic syndrome in human. It was prepared
according to previous studies from our laboratory with rodents [10], as well as to recommendations of
the American Institute of Nutrition (AIN-93M) [11]. Considering that oat flour was present in snack
formulation, starch for OC diet came from oat and wheat flour in similar amounts. Body weight
and food intake were measured daily. At the end of the total experimental period (12 weeks), rats
from the five experimental groups were sacrificed after a 12 h of fasting under anesthesia (chloral
hydrate) by cardiac exsanguination. Serum was obtained from blood samples after centrifugation
(1000 g for 10 min, at 4 ◦C). Livers were dissected, weighed, and immediately frozen in liquid nitrogen.
All samples were stored at −80 ◦C until analysis.
2.3. Serum Parameters
Commercially available spectrophotometric kits were used for total cholesterol, HDL-cholesterol,
non-esterified fatty acids (NEFA) (Biosystems, Barcelona, Spain), TG (Spinreact, Barcelona, Spain) and
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transaminases (Spinreact, Barcelona, Spain) determinations. Non-HDL-cholesterol was calculated by
subtracting the quantity of HDL-cholesterol to total cholesterol.
2.4. Liver Composition
Total liver lipids were extracted according to the method described by Folch et al. [12]. The lipid
extract was dissolved in isopropanol and the TG and phospholipid content were measured using
a commercial kit (Spinreact, Barcelona, Spain). Protein contents was analyzed using the Lowry
method [13] and water content was measured gravimetrically by drying samples at 105 ◦C until a
constant weight was reached.
2.5. Oxidative Stress Determinants
Lipid peroxidation was determined spectrophotometrically by measuring the formation of
thiobarbituric acid reactive species (TBARS) in liver homogenates using a commercial kit (TBARS
Assay Kit, Cayman Chemical Company, Ann Arbor, MI, USA). The TBARS concentrations on the
samples were calculated using a standard curve obtained with malondialdehyde (MDA). Superoxide
dismutase (SOD) was assessed spectrophotometrically, using a commercial kit (Superoxide Dismutase
Activity Assay Kit, BioVision Incorporated, Milpitas, CA, USA).
2.6. Enzyme Activities
The activity of the lipogenic enzyme fatty acid synthase (FAS) was measured by
spectrophotometry, as previously described [14]. Briefly, liver samples (0.5 g) were homogenized
in 5 mL of buffer (150 mM KCl, 1 mM MgCl2, 10 mM N-acetyl cysteine and 0.5 mM dithiothreitol)
and centrifugated to 100,000g for 40 min at 4 ◦C. The supernatant fraction was used for FAS activity
determination, as the rate of malonyl CoA dependent NADH oxidation [15]. Results were expressed as
nanomoles of reduced nicotinamide adenine dinucleotide phosphate (NADPH) consumed per minute
per milligram of protein. Liver pyruvate kinase activity was measured by fluorimetry, according to the
manufacturer’s protocol (BioVision, Milpitas, CA, USA).
As far as oxidative enzymes are concerned, carnitine palmitoyltransferase-1a (CPT-1a) activity
was measured spectrophotometrically in the mitochondrial fraction as previously described [16]. The
activity was expressed as nanomoles of coenzyme A formed per minute per milligram of protein.
Citrate synthase (CS) activity was assessed spectrophotometrically following the Srere method [17], by
measuring the appearance of free CoA. Briefly, frozen liver samples were homogenized in 25 vol (w/v)
of 0.1 M Tris-HCl buffer (pH 8.0). Homogenates were incubated for 2 min at 30 ◦C with 0.1MTris-HCl
buffer containing 0.1 mMDTNB, 0.25 Triton X-100, 0.5 mMoxalacetate and 0.3 mM acetyl CoA, and
readings were taken at 412 nm. Then, the homogenates were re-incubated for 5 min and readings were
taken at the same wavelength. CS activity was expressed as CoA nanomoles formed per minute, per
milligram of protein. The protein content of the samples was determined by the Bradford method [18],
using bovine serum albumin as standard.
In order to assess the assembly and secretion of very low-density lipoproteins by the liver,
microsomal TG transfer protein (MTP) activity was determined fluorometrically by using a commercial
kit (Sigma-Aldrich, St. Louis, MI, USA). MTP activity was expressed as percentage of transference.
2.7. RNA Extraction and Real Time RT-PCR
RNA samples from 100 mg of hepatic small lobe were extracted using Trizol (Invitrogen, Carlsbad,
CA, USA), according to the manufacturer’s instructions. After RNA purity verification, samples were
then treated with DNase I kit (Applied Biosystems, California, USA) to remove any contamination
with genomic DNA. 1.5 µg of total RNA of each sample was reverse-transcribed to first-strand
complementary DNA (cDNA) using iScriptTM cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA).
Relative mRNA levels of cpt1a, cox2, nduf, cs, ucp2, pparα, tfam, slc2a5, slc2a2, pnpla, lipe, cd36,
acsl1, acsl5 and 18 s were quantified using real-time PCR with an iCyclerTM - MyiQTM real time
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PCR detection system (BioRad, Hercules, CA, USA). For cpt1a, cox2, nduf, cs, ucp2, pparα, and tfam
SYBR Green Master Mix (Applied Biosystems, Foster City, CA, USA) was used. The upstream
and downstream primers and probe (TibMolbiol, Berlin, Germany, Eurogentec, Liège, Belgium
and Metabion, Munich, Germany) were previously described [19,20]. fatp2, fatp5, cd36, acsl1, acsl5,
pk, fasn, dgat1, dgat2, chreb, srebf, acaca, lxrα, pnpla, lipe, and 1 8s were measured by TaqMan®
Gene Expression Assays (Rn00581971_m1, Rn00577177_m1, Rn00580728_m1, Rn00563137_m1,
Rn00586013_m1, Rn01455286_m1, Rn00569117_m1, Rn00584870_m1, Rn01506787_m1, Rn00591943_m1,
Rn01495769_m1, Rn00573474_m1, Rn00581185_m1, Rn01479965_g1, Rn00689222_m1, Rn03928990_g1)
and TaqMan® fast advanced master mix (Applied Biosystems, Foster City, CA, USA). RT-PCR
parameters used were those defined by manufacturer’s. 18 s mRNA levels were similarly measured
and served as the reference gene. All gene expression results were expressed as fold changes of
threshold cycle (Ct) value relative to controls using the 2−∆∆Ct method [21].
2.8. Western Blot
Liver samples (100 mg) from the small lobe were homogenized in 1000 µL of cellular PBS
buffer (pH 7.4), containing protease inhibitors (100 mM phenylmethylsulfonyl fluoride and 100
mM iodoacetamide). Then, homogenates were centrifuged (800g for 10 min at 4 ◦C) and protein
concentrations measured by Bradford method [18], using bovine serum albumin as standard.
Immunoblot analyses were carried out using 60 µg of liver protein extracts which were separated
by electrophoresis in precast 7.5% SDS-polyacrylamide gels (Bio-Rad, Hercules, CA, USA) and
transferred to PVDF membranes (Merck Millipore, Cork, IRL). The membranes were then blocked
with 5 % caseine PBS-Tween buffer for 2 h at room temperature and, subsequently, blotted with
the appropriate antibodies overnight at 4 ◦C. Protein levels were detected via specific antibodies
for FATP2 (1:1000), GLUT5 (1:1000) (Santa Cruz Biotech, Dallas, TX, USA), AMPK (1:1000), FATP5
(1:1000) (LifeSpan BioScience, Seattle, WA, USA), GLUT2 (Thermo Fisher Scientific, Rockford, IL,
USA), and β-Actin (1:5000) (Sigma, St Louis, MO, USA). Afterward, polyclonal anti-mouse for GLUT5
and β-Actin (1:5000) (Santa Cruz Biotech, Dallas, TX, USA), anti-goat for FATP2 (1:5000) (Santa Cruz
Biotech, Dallas, TX, USA) and anti-rabbit for FATP5 and GLUT2 (1:5000) (Santa Cruz Biotech, Dallas,
TX, USA) were incubated for 2 h at room temperature, and the levels of the afore mentioned proteins
were measured. The bound antibodies were visualized by an ECL system (Thermo Fisher Scientific Inc.,
Rockford, IL, USA) and quantified by a ChemiDoc MP Imaging System (Bio-Rad, Hercules, CA, USA).
Specific bands were identified by using a standard loading buffer (Precision Plus protein standards
dual color; ref. 161-0374 Bio-Rad).
2.9. Statistical Analysis
Results are presented as mean ± SEM. Statistical analysis was performed using SPSS 21.0 (SPSS,
Chicago, IL, USA). All the variables were normally-distributed according to the Shapiro–Wilks test.
Data were analyzed by one-way ANOVA followed by Newman–Keuls post hoc test. Significance was
assessed at the p < 0.05 level.
3. Results
3.1. Effect of the Snacks on Liver Weight and Liver Composition
Table 1 shows body weight, liver weight and liver composition of control and snack-treated rats.
When comparing rats showing MetS with those fed the different experimental diets, even though no
changes in body weight were found, liver weight/body weight ratio was significantly lower in rats
fed the wheat and oat control diets, as well as in rats treated with both snacks when compared to
the control group. Liver composition analysis revealed that both control and snack-treated groups
had lower TG and phospholipid content in liver than not treated rats showing MetS. Moreover, in
the case of SB rats, the percentage of liver TG was even lower than that of WC group. Liver protein
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percentage remained unchanged with any of the control diets although an increase was observed after
snack A consumption. Liver water content increased in OC rats treated and remained unchanged after
snack treatment.
Table 1. Final body weight, liver weight, and liver composition of experimental groups.
MS WC OC SA SB
Final body weight (g) 412.0 ± 10.0 456.0 ± 14.0 449.0 ± 5.0 441.0 ± 8.0 448.0 ± 12.0
Liver weight (g) 15.5 ± 0.6 a 15.0 ± 0.3 a 14.8 ± 0.7 a 13.9 ± 0.7 a 13.8 ± 0.7 a
Liver/body weight 3.7 ± 0.1 a 3.3 ± 0.1 b 3.3 ± 0.1 b 3.1 ± 0.1 b 3.1 ± 0.1 b
Liver composition:
Triglycerides (%) 5.31 ± 0.51 a 4.29 ± 0.39 b 3.66 ± 0.41 b,c 3.43 ± 0.29 b,c 3.15 ± 0.35 c
Phospholipids (%) 2.14 ± 0.11 a 2.29 ± 0.15 b 2.10 ± 0.13 b 2.90 ± 0.27 b,c 2.26 ± 0.08 c
Protein (%) 13.2 ± 0.5 b 16.2 ± 1.3 a,b 15.0 ± 0.9 a,b 16.8 ± 0.6 a 16.1 ± 1.1 a,b
Water (%) 61.4 ± 1.0 b 64.0 ± 0.9 b 72.9 ± 0.9 a 66.6 ± 1.2 b 65.3 ± 1.5 b
Values are means ± SEM. Values in the same row with different subscript are significantly different at p < 0.05.
In the case of water values, different letters mean p < 0.001. MS: metabolic syndrome; WC: wheat control; OC: oat
control; SA: snack A; SB: snack B.
3.2. Effect of the Snacks on Serum Parameters
When serum parameters were analyzed, MS rats showed lower TG values than the rats fed the
control diets (Table 2). However, snack-treatment (A and B) reduced serum TG concentration when
compared to control diet fed rats and reached the same level than that of MS rats. While control
diets did not modify serum NEFA levels, both snacks effectively reduced them. Regarding to
plasma cholesterol levels, although total and HDL-cholesterol values were similar among all the
experimental groups, non-HDL cholesterol levels were lower in all groups compared to MS. However,
no snack-induced effect was observed on this parameter. As far as plasma transaminases (GOT and
GPT) are concerned, neither snack A nor snack B modified these parameters comparing to MS or
control groups.
Table 2. Serum parameters in rats fed on the experimental diets.
MS WC OC SA SB
Triacylglycerol (mg/L) 37.1 ± 6.4 b 64.0 ± 22.8 a 46.6 ± 15.4 a,b 37.4 ± 11.0 b 40.6 ± 18.4 b
NEFA (mmol/L) 0.51 ± 0.10 a 0.44 ± 0.12 a,b 0.39 ± 0.09 a,b 0.35 ± 0.04 b 0.29 ± 0.03 b
Total cholesterol (mg) 150.0 ± 23.4 147.1 ± 15.9 143.0 ± 12.0 142.1 ± 19.6 136.7 ± 5.8
HDL-cholesterol (mg) 13.9 ± 4.3 a 10.2 ± 1.9 b 10.7 ± 2.1 a,b 11.2 ± 2.6 a,b 11.1 ± 0.7 a,b
Non-HDL-cholesterol 136.1 ± 23.3 a 136.9 ± 15.7 b 131.2 ± 11.2 b 130.9 ± 20.3 b 125.0 ± 6.0 b
Transaminases
GPT (U/L) 42.0 ± 4.3 25.9 ± 1.7 29.0 ± 2.1 38.7 ± 6.6 32.4 ± 4.7
GOT (U/L) 124.8 ± 5.3 a,b 109.5 ± 3.3 a,b 127.3 ± 5.9 a,b 155.3 ± 25.3 a 96.2 ± 11.1 b
Values are means ± SEM. Values in the same row with different subscript are significantly different at p < 0.05.
In the case of NEFA, p value for the comparison between MS and SB is p < 0.01. NEFA: non sterified fatty acid, HDL:
high density liporpotein, ALT: alanine aminotransferase, AST: aspartate aminotransferase. MS: metabolic syndrome;
WC: wheat control; OC; oat control; SA: snack A; SB: snack B.
3.3. Effect of the Snacks on Oxidative Stress
In relation to oxidative stress related parameters, treatment with both control diets reduced
TBARS levels. In the case of OC diet, dropped SOD activity was also appreciated (Figure 1A,B). in
the same line, both snacks reduced TBARS levels when comparing to MS group, although no changes
were observed when comparing to control groups. SOD activity remained unchanged in the case of
snack A, while an increase was found after snack B ingestion.
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(A) Oxidative genes mRNA levels, (B) CPT activity, and (C) CS activity. Values are expressed as mean 
± SEM. Values not sharing a common letter are significantly different (p < 0.05). In the case of CPT1a 
and CS activities, p value for the comparisons SM and SB groups or OC and SB groups is p < 0.001. 
3.5. Effect of the Snacks on Lipogenesis Related Gene Expression and Enzyme Activity 
OC diet did not modify the expression of any of the genes involved in lipogenesis (Figure 3A) 
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3.4. Effect of the Snacks on β-Oxidation Related Gene Expression and Enzyme Activity
Gene expression of genes and transcription factors involved in liver β-oxidation in liver was
analyzed (Figure 2A). Oat control diet did not modify any of the analyzed genes, with the exception
of cox2, which was significantly higher. However, oxidative enzyme activities remained unchanged
(Figure 2B,C). Snack A increased nduf mRNA levels comparing to MS group (Figure 2A). Snack B
treatment increased CPT and CS activities and snack A only that of CS (Figure 2B,C).
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Figure 2. Effects on fatty acid oxidation of MetS rats ( S, n = 10), rats fed with wheat control diet
(WC, n = 10), wheat and oat control diet (OC, n = 10), A snack (SA, n = 10), and B snack (SB, n = 10).
(A) Oxidative genes mRNA levels, (B) CPT activity, and (C) CS activity. Values are expressed as mean
± SEM. Values not sharing a common letter are significantly different (p < 0.05). In the case of CPT1a
and CS activities, p value for the comparisons SM and SB groups or OC and SB groups is p < 0.001.
3.5. Effect of the Snacks on Lipogenesis Related Gene Expression and Enzyme Activity
OC diet did not modify the expression of any of the genes involved in lipogenesis (Figure 3A)
or FAS activity (Figure 3B), but reduced PK activity (Figure 3C). Treatment with snack A enhanced
lipogenic gene expression when compared to MS group, but without modifying any parameter when
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compared to OC group. Snack B only increased chreb mRNA levels (Figure 3A). None of the tested
snacks modified FAS or PK activities (Figure 3B,C).
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Figure 3. Effects on fatty acid synthesis of MetS rats ( S, n = 10), rats fed with wheat control diet (WC,
n = 10), wheat and oat control diet (OC, n = 10), A snack (SA, n = 10), and B snack (SB, n = 10). (A) Fatty
acid synthesis involved genes mRNA levels, (B) FAS activity and (C) PK activity. Values are expressed
as mean ± SEM. Values not sharing a common letter are significantly different (p < 0.05). In the case of
cherb gene expression, p value for the comparison between MS, OC and SA is p < 0.01.
3.6. Effects of the Snacks on the Expression Of Genes Involved in Lipolysis, Triacylglycerol Re-Esterification
and Release
No changes were observed in lipases gene expression among the different experimental groups
(data not shown). dgat1 and dgat2 gene expressions were measured in order to see the effects on TG
assembly. OC diet increased dgat2 mRNA levels when compared to MS group (Figure 4A). By contrast,
no snack-treatment effect was observed. Moreover, MTP activity was measured in order to clarify
whether snacks administ ati n reduced TG synthesis in liv r through th s enzyme, but significant
changes were not observed among all the experimental groups (Figure 4B).
Nutrients 2018, 10, x FOR PEER REVIEW  7 of 14 
 
lipogenic gene expression when compared to MS group, but without modifying any parameter when 
com ared to OC group. Snack B only increased ch eb mRNA levels (Figure 3A). None of the tested 
sna ks modified FAS r PK activities (F gu  3B,C). 
 
(A) 
 
(B) (C) 
Figure 3. Effects on fatty acid synthesis of etS rats (MS, n = 10), rats fed with wheat control diet (WC, 
n = 10), wheat and oat control diet ( ,   ),  snack (SA, n = 10), and B snack (SB, n = 10). (A) Fatty 
acid synthe is involved genes  , ( ) F S activity and (C) PK activity. Values are express d 
as mean ± SE . alues n t    let er are significantly different (p < 0.05). In the case of 
cherb gen  expression, p value for the  t een S, OC and SA is p < 0. 1. 
3.6. Effects of the Snacks on the Expression Of Genes Involved in Lipolysis, Triacylglycerol Re-Esterification 
and Release 
No changes were observed in lipases gene expression among the different experimental groups 
(data not shown). dgat1 and dgat2 gene expressions ere measured in order to see the effects on TG 
assembly. OC diet increased dgat2 mRNA levels when compared to MS group (Figure 4A). By 
co tr st, no snack-tre tment effect was observ d. Moreover, MTP activity w  m asured in order to 
clarify whether snack  admi istration reduced TG y thesis in liver ro gh this enzyme, but 
significant changes wer  not observed among all the expe imental roups (Figure 4B). 
  
(A) 
b
b b
a,b
a,b
b
a
a
ba,b
a.b
a
0
1
2
3
4
5
6
acaca fasn lxr1α chreb srebf1 pk
Fa
tty
ac
id
sy
nt
he
sis
re
lat
ed
ge
ne
 ex
pr
es
sio
n
(a
rb
itr
ar
yu
nit
s)
MS
OC
SA
SB
0
200
400
600
800
1000
1200
1
FA
S 
ac
tiv
ity
 (n
m
ol
 Co
A/
m
in
/m
g 
pr
ot
)
SM
OC
SA
SB
0
5
10
15
20
25
30
35
40
SM OC SA SB
PK
 a
ct
iv
ity
(n
m
ol
/m
in
/m
g p
ro
te
in
)
SM
OC
SA
SB
b
a
a,b
a,b
0.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
dagt1 dgat2
Di
ac
ylg
lyc
er
ol
 tr
an
sfe
ra
se
s m
RN
A 
le
ve
ls 
(a
rb
itr
ar
y 
un
its
)
MS
OC
SA
SB
Figure 4. Cont.
Nutrients 2019, 11, 86 8 of 14
Nutrients 2018, 10, x FOR PEER REVIEW  8 of 14 
 
 
(B) 
Figure 4. Effects on triacylglycerol re-esterification and triacylglycerol release of MetS rats (MS, n = 
10), rats fed with wheat control diet (WC, n = 10), wheat and oat control diet (OC, n = 10), A snack 
(SA, n = 10), and B snack (SB, n = 10). (A) triacylglycerol re-esterification involved genes mRNA levels 
and (B) MTP activity. Values are expressed as mean ± SEM. Values not sharing a common letter are 
significantly different (p < 0.05). 
3.7. Effect of the Snacks on Fatty Acid Uptake Related Gene and Protein Expression 
With regard to genes involved in liver fatty acid uptake, only in the case of SB group reduced 
gene expression of acsl1 when compared to OC and SA group was observed (Figure 5A). Neither OC 
diet nor snacks A and B modified protein expression of FATP2 and FATP5 (Figure 5B,C). 
 
(A) 
 
(B) 
0
10000
20000
30000
40000
50000
60000
70000
mtp
M
TP
 ac
tiv
ity
 (t
ra
ns
fe
re
nc
e 
%/
tis
su
e g
/h
ou
r)
MS
OC
SA
SB
a,b
a a
b
0,0
0,5
1,0
1,5
2,0
2,5
3,0
fatp2 fatp5 acsl1 acsl5 cd36
Fa
tty
 a
cid
 up
ta
ke
 re
lat
ed
 g
en
e e
xp
re
ss
ion
 
(a
rb
itr
ar
y 
un
its
)
MS OC SA SB
Figure 4. Effects on triacylglycerol re- sterification and triacylglycerol release of MetS rats (MS, n = 10),
rats fed with wheat control diet (WC, n = 10), wheat and oat control diet (OC, n = 10), A snack (SA,
n = 10), and B snack (SB, n = 10). (A) triacylglycerol re-esterification involved genes mRNA levels
and (B) MTP activity. Values are expressed as ean ± SEM. Values not sharing a co mon letter are
significantly different (p < 0.05).
3.7. Effect of the Snacks on Fat y Acid pt e and Protein Expre sion
With regard to genes involved in li f tt i ptake, only in the case of SB group reduced
gene expression of acsl1 when co pare to a S group was observed (Figure 5A). Neither OC
diet nor snacks A and B modified protein expression of F TP2 and F TP5 (Figure 5B,C).
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Figure 5. Effects on fatty acid uptake of MetS rats (MS, n = 10), rats fed with wheat control diet (WC, n =
10), wheat and oat control diet (OC, n = 10), A snack (SA, n = 10), and B snack (SB, n = 10). (A) Fatty acid
uptake involved genes mRNA levels, (B) FATP2 protein levels and (C) FATP5 protein levels. Values are
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In the case of acsl1 gene expression, p value for the comparison between OC and SA vs. SB is p < 0.01.
3.8. Effect of the Snacks on Glucose Uptake Related Gene and Protein Expression
No changes were observed in glut2 and glu 5 gene expressio or rotei level (Figure 6A–C)
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4. iscussion
The present study aimed to analyze the potential beneficial effects of new snacks, formulated
by using wakame and carob pod, in the treatment of liver steatosis in rats showing etS. For this
purpose, once etS as induced in rats by a high-fat high-fructose feeding, the animals were then fed
a diet in which complex carbohydrates were replaced with the functional snacks. Wakame and carob
pod were chosen as functional ingredients for the snack preparation, taking into account the results
from our previous research in cell cultures and sensory-panel [22,23]. The WC group included rats
fed a standard diet, representing the commonly used dietary strategy of non-healthy dietary patterns
normalization. In addition, taking into account the carbohydrate source of the snacks, the OC group
was included as a better control group for snack-fed groups.
It has been reported that insulin resistance is one of the ain factors involved on the
etiopathogenesis of liver steatosis. In fact, NAFLD is considered the hepatic manifestation of MetS [24].
In the present study rats with MetS effectively showed liver mild steatosis because hepatic triglyceride
amount was slightly greater than 5% [25]. As expected, the switch from a high-fat high-fructose
diet to a standard one (WC or OC) led to a significant reduction in this parameter. The reductions
induced by both snacks were higher than those observed in control groups, although without statistical
significance. In spite of these changes, transaminase levels remained unchanged. Concerning this issue,
it is important to emphasize that although transaminases are commonly used as biomarkers of fatty
liver, they are not reliable markers since their levels can be normal even in advanced NAFLD [24,26].
In addition, reductions in liver steatosis without changes in transaminase levels have been described
in the literature [27,28].
In order to gain ore insight concerning the effects of the functional snacks, the expression of
genes involved in hepatic triglyceride etabolis ere analyzed. In these easure ents, only OC
was included as the control group in order to differentiate whether the observed effect was due to the
functional ingredients of the snack or to the oat. No significant changes were observed in liver from rats
treated with these snacks in the expression of key enzymes that play a key role in de novo lipogenesis,
(acaca and fasn), and pk, nor in the expression of transcriptional factors regulating this metabolic
process (srebf1 or cherb) when compared to the control groups. In addition, the activities of PK and FAS
remained unchanged. A similar situation was observed when gene and protein expressions of fatty
acid transporters, such as FATP2 or FATP5, were assessed. Snack treatment did not modify glucose
uptake, either. However, when fatty acid oxidation pathway was analyzed, although no changes in
gene expression were found, both snacks increased the activity of CTP-1a, when compared to the
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control groups. Additionally, the snack B, which contained more wakame seaweed percentage, also
significantly increased the activity of CS. These results suggest that functional snacks could increase
fatty acid oxidation, thus reducing fatty acid availability for TG synthesis. TG assembly, another
important process involved in TG synthesis, was also analyzed. Snack B, but not snack A, significantly
reduced the gene expression of dgat1, when compared to the control groups. Whereas dgat2 function
is closely linked to endogenous fatty acid synthesis and esterification, dgat1 may be involved in the
recycling of hydrolyzed TG by re-esterifying the fatty acids [29]. Thus, this pathway could represent
another mechanism by which snack B reduced hepatic fat content.
Our results cannot be compared with those obtained in other studies since the snacks used in
the present study have not been previously used. Nevertheless, we can consider reported studies
carried out with wakame or carob pod used independently. In this sense, our results are in agreement
with those reported by Murata et al. [6]. They found that dietary wakame decreased rat liver TG level
due to increased activities of enzymes involved in the fatty acid oxidation in mitochondria. In a more
recent study, carried out in growing rats (four weeks old), Yoshinaga et al. showed that 1% of wakame
administration was useful for MetS prevention [30]. Through a DNA array, this research proposed that
the administration of wakame downregulated the up-stream transcription factor SREBF-1, leading to
fatty acid synthesis inhibition, and upregulated the transcription factor PPARα, thus increasing fatty
acids transport into mitochondria for β-oxidation and bile acid biosynthesis. Although the purpose of
our study and the work conducted by Yoshinaga et al. was different [30], MetS prevention in the case
of Toshinaga et al., and MetS treatment in the present study, as well as the maturation state of rats,
growing or young-adult rats, fatty acid oxidation was proposed as mechanism of action of wakame in
both studies.
With regard to carob pod, a study conducted in rabbits revealed that an eight-week treatment
with insoluble fiber obtained from carob pod, rich in polyphenols, prevented dyslipidemia.
Supplementation with this polyphenol-rich fiber increased liver expression of SIRT1 and PGC-1α, and
modulated key factors involved in hepatic lipid metabolism [31].
The differences observed in TG metabolism among rats fed in functional snacks and control rats
do not fit well with the lack of differences observed among these groups in terms of hepatic TG content.
A possible explanation could be that the changes induced by the snacks were not big enough to induce
a significantly higher reduction on this parameter. Furthermore, it could hypothesized that perhaps a
longer period of treatment could enhance the positive effects of the snacks.
Taking into account the results concerning hepatic TG content, it seems that the functional
snacks do not represent an advantage with regard to the improvement induced by dietary pattern
normalization. Nevertheless, when assessing the treatment of NAFLD, other additional aspects such
as oxidative stress should be considered. It has been demonstrated that high-fructose feeding causes
fat deposition in the liver and induces oxidative stress, essentially through the deterioration of the
antioxidant defense system [32]. Moreover, elevated oxidative stress and subsequent lipid peroxidation
have been reported to play a crucial role in the pathogenesis of MetS, and it is well known that they
are essential in the progression from NAFLD to steatohepatitis [33–36].
When oxidative stress was analyzed, it was observed that in rats treated with the snack B SOD
values were significantly increased, meaning that it exerted an anti-oxidant effect. Bearing in mind the
difference among rats treated with the snack B and the control groups, it can be proposed that wakame
seaweed, and more precisely its polyphenols as well as fucoxanthine derived liver metabolites, can be
responsible for this anti-oxidant effect [5,37].
One limitation of the present study is that dietary carbohydrates were totally replaced by
functional snacks, an experimental condition that cannot be reproduced in human trials. In view of
this situation, we are working in an ongoing intervention human study, where subjects with MetS
receive 50 g of formulated functional snack per day. Moreover, considering that several studies have
shown that female gender is a risk factor for NAFLD [38], the results obtained in this study in male
rats cannot be directly extrapolated to females. Finally, it must be pointed out that performing liver
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immunohistochemistry assays could have given an additional approximation to the NAFLD diagnosis
carried out by measuring hepatic TG content.
Altogether, the results obtained show that, under the present experimental conditions, snack
B can be considered as an interesting tool for fatty liver treatment because it induces not only a
reduction in triglyceride amount, but also a reduction in oxidative stress. Thus, a greater amelioration
of NAFLD than that obtained by switching rats to a standard feeding pattern can be achieved by the
proposed snack.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/11/1/86/s1,
Figure S1: Flowchart of the experimental design.
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